Clinical Trial Update: A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009) [Phase 1]

View source ↗

Summary

Phase 1 study of ascending multiple oral doses of surotomycin in healthy participants has completed, evaluating safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Surotomycin (surotomycin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Clostridium Difficile Associated Diarrhea (CDAD) | Phase 1 | Status: COMPLETED